Posted by infectedmushrooms on September 27, 2007, at 16:50:08
In reply to Is this true about resperidol? Is Breggin Real?, posted by Phillipa on September 25, 2007, at 21:34:24
why wouldn't it be real just because it is on the internet everything is fake?...people do sue drug companies and cases are won sometimes i don't see why this would be different...Breggin was a former psychiatrist who sold his soul to the devil until he realized he had to redeem himself by telling the medical community and patients the truth of taking psychiatric drugs that get approved by the FDA...so i would think the case is real...one thing they fail to mention is how is her sex drive now after taking risperdal...i wonder why that is not mentioned b/c that would piss me off more than anything as risperdal ruins hormones permanently after taking it for as long as she took it so i would say she is definitely libidoless now and has secondary hypogonadism...this drug ruined her in more ways than one...So now this woman has a movement disorder and no sex life anymore...nice payoff i guess *cough *cough not really...
> I google reperidol from a thread on here and got this is it true or is it just something on the net. As I haven't heard of any lawsuits with resperidol. Phillipa
>
> Psychiatric Drug Facts
> Peter R. Breggin, M.D.
> $6.7 million awarded in Risperdal tardive dyskinesia case
>
> On May 26, 2000, a jury in the circuit court of Philadelphia awarded $6.7 million to a patient afflicted with tardive dyskinesia caused by the neuroleptic ("antipsychotic") drug Risperdal (generic name, risperidone). In Liss vs. Doeff, the jury found the psychiatrist negligent in his treatment of Mrs. Elizabeth Liss. The case is among the first involving Risperdal, a relatively new neuroleptic that was put on the market in 1994 and originally promoted as relatively free of the risk of tardive dyskinesia. Peter R. Breggin, M.D., referred the case to the attorneys and acted as a medical consultant throughout the case.
>
> Ms. Liss developed tardive dyskinesia during a fourteen-month period of exposure to Risperdal as a maintenance treatment for manic-depressive (bipolar) disorder. In previous years, she had several relatively brief exposures to other neuroleptics.
>
> Tardive dyskinesia is a movement disorder caused by neuroleptic or "antipsychotic" medications. It can afflict any voluntary muscles of control. It can become severe and disabling, and there are no effective treatments. Studies of older neuroleptics such as Haldol, Navane, Prolixin, and Thorazine have demonstrated a cumulative risk of 4%-8% per year for the development of this disorder. Thus, the risk developing tardive dyskinesia during a five-year exposure to neuroleptics is in the astronomical range of 20%-40%. Among the elderly cumulative rates can surpass 20% per year. Tardive dyskinesia also afflicts children.
>
> As yet there is insufficient data to predict the exact rates of tardive dyskinesia for newer, atypical neuroleptics such as Risperdal, Zyprexa (olanzapine), and Seroquel (quetiapine). However, prudent physicians should assume that all neuroleptic drugs are associated with a high risk of tardive dyskinesia.
>
> Mrs. Liss suffered from a form of tardive dyskinesia called tardive dystonia. The dystonia caused Mrs. Liss to suffer from disfiguring facial grimaces and painful neck spasms. In addition, she was afflicted with abnormal movements of her tongue, jaw, and mouth, impaired swallowing, occasionally irregular breathing, and abnormalities in her hands and walking.
>
> The case was significant in regard to the large award of $6.7 million for a patient who was not completely disabled. Although requiring frequent periods of rest, and experiencing disfigurement and physical discomfort, she was able to carry out household tasks and to work outside the home.
>
poster:infectedmushrooms
thread:785198
URL: http://www.dr-bob.org/babble/20070919/msgs/785555.html